A research team is preparing to run an important experiment.
The instruments are calibrated. The samples are ready. Researchers have reserved laboratory time, and the project timeline depends on the results.
Then IT discovers something concerning.
A workstation connected to one of the laboratory instruments is running an outdated operating system.
The computer communicates with the lab's network, stores experimental information, and depends on specialized software that hasn't been updated in years.
The IT team's first instinct is to install security updates.
But the laboratory manager explains that an untested software change could interfere with the instrument's operation or vendor-supported configuration.
Now the organization faces an uncomfortable decision.
How do you strengthen cybersecurity without disrupting the scientific work your technology exists to support?
This is a critical question for biotechnology and life sciences organizations.
Modern laboratories rely on connected technology, but not every device can be managed like a typical office computer.
Protecting these environments requires coordination between researchers, IT specialists, instrument vendors, and leadership.
In a traditional office environment, computers generally use familiar operating systems, productivity applications, and standardized management tools.
Laboratories can be more complicated.
A biotech organization might rely on:
Some of these systems depend on specific software versions, hardware configurations, or maintenance procedures.
A security change that works perfectly on an office laptop may not be appropriate for an instrument workstation.
That doesn't mean the equipment should remain unprotected.
It means organizations need a risk-based security approach that considers operational requirements.
Consider a hypothetical biotech laboratory that has expanded over several years.
New researchers have joined the company. Additional instruments have been installed, and the network has grown.
But one workstation has been supporting the same piece of laboratory equipment since the organization opened.
The system still works.
Researchers depend on it.
Nobody has wanted to interfere with its configuration.
Unfortunately, the device was never fully incorporated into the company's ongoing cybersecurity management process.
IT may not know which software it runs, who maintains it, whether it receives security updates, or what information it can access.
The issue isn't necessarily that somebody ignored cybersecurity.
The problem is that responsibility for the system was never clearly established.
Equipment that operates reliably can still introduce security risks if nobody knows how it is maintained or protected.
The first step is visibility.
A laboratory technology inventory should record relevant information such as:
The inventory should identify which devices are critical to research operations and which systems require special handling.
This helps organizations make informed decisions rather than applying broad technical changes without understanding the consequences.
Not every instrument needs unrestricted access to an entire corporate network.
Network segmentation can help limit communication between laboratory devices, general business systems, and other network environments.
For example, a workstation that only needs to communicate with a specific instrument and approved research storage may not require direct access to unrelated business applications.
Appropriate segmentation can reduce potential exposure while preserving necessary functionality.
However, network changes should be evaluated against instrument requirements, validated workflows, and vendor recommendations.
The objective is controlled communication, not arbitrary isolation.
Routine patch management is important, but specialized systems may need a different approach.
Before updating an instrument workstation, determine:
When an update cannot be applied promptly, the organization should assess the risk and consider compensating controls.
These could include access restrictions, network segmentation, additional monitoring, or other protections appropriate to the environment.
Leaving a system unpatched indefinitely should not become the default without a documented risk decision.
Instrument vendors sometimes require remote connectivity for troubleshooting or maintenance.
That access should be managed carefully.
Organizations should understand who can connect, how authentication works, whether access can be restricted to approved maintenance periods, and what activity is recorded.
Unnecessary persistent remote access can create avoidable exposure.
A controlled vendor access process helps protect both the equipment and the broader network.
Laboratory-connected systems may store experimental measurements, analysis results, instrument configurations, and other valuable information.
Organizations should identify what must be preserved and how it can be recovered.
Some information may require specialized backup procedures or vendor involvement.
For a deeper discussion of recovery planning, see Research Data Backup and Recovery for Biotech Labs.
Who receives a security alert involving a laboratory workstation?
Who decides whether the device should be disconnected?
Who contacts the instrument vendor?
Who determines when research activities can safely resume?
These questions should be answered before an incident occurs.
IT and laboratory leadership should agree on an incident response process that considers security requirements, research continuity, and the operational impact of containment actions.
Biotechnology organizations may operate under different regulatory and contractual requirements depending on their research, manufacturing activities, records, and products.
Not every laboratory instrument is an FDA-regulated medical device, and not every biotech organization has the same compliance obligations.
For FDA-regulated medical devices, the agency has published guidance addressing cybersecurity risks and appropriate lifecycle considerations.
Other laboratory environments may need to consider applicable electronic-record requirements, quality procedures, contractual obligations, or internal validation processes.
The important principle is to identify which requirements actually apply rather than assuming that one regulatory framework covers every laboratory system.
Organizations should involve their quality and regulatory personnel when changes may affect validated systems or regulated records.
If your organization relies on connected laboratory equipment, start with these questions:
You don't need every answer immediately.
But knowing where the gaps exist gives leadership a starting point for prioritizing improvements.
At V.I. Experts, we understand that technology in a research environment needs to support both security and operational reliability.
Our IT Support for Biotech Companies services focus on protecting sensitive information, strengthening cybersecurity, supporting reliable infrastructure, and helping organizations scale their technology environments.
We help organizations approach IT challenges with attention to the work their researchers depend on.
For additional context, read Biotech IT Support: Keeping Research Moving When Technology Matters Most.
Connected laboratory systems may process valuable research information or communicate with broader business networks. Security weaknesses can create risks involving unauthorized access, data exposure, or operational disruption.
Sometimes. Risk-reduction measures may include network segmentation, restricted access, enhanced monitoring, and vendor-supported maintenance. The appropriate approach depends on the equipment, security risks, and available support options.
Not necessarily. Some instrument-connected systems require vendor approval, compatibility testing, or validation before updates. Organizations should establish a risk-based maintenance process rather than applying uncontrolled changes.
No. The applicability of FDA requirements and guidance depends on the equipment, products, regulated activities, and other circumstances. Organizations should evaluate their specific obligations with appropriate regulatory expertise.
Scientists shouldn't have to choose between keeping an experiment running and protecting the systems that support it.
With appropriate planning, communication, and technical safeguards, biotechnology organizations can reduce cybersecurity risks while respecting the operational needs of specialized equipment.
The goal isn't to make every laboratory device behave like an office computer.
It's to develop a security strategy that understands the environment it protects.
Because the technology behind a scientific breakthrough deserves protection that supports the science, not protection that gets in its way.
Is your laboratory technology receiving the attention it needs?
